// App-Quantinova.ai

2220 : PD-L1 expression in primary tumor and circulating tumor cells in patients with small cell lung carcinomas

Researchers

Presenter

  • Marius Ilie

Principal Investigators

  • Veronique Hofman

  • Elodie Long

  • Catherine Butori

  • Salome Lalvee

  • Eric Selva

  • Nicolas Venissac

  • Jerome Mouroux

  • Charles Hugo Marquette

  • Paul Hofman

Medical Centers

  • CHU Nice, Laboratory of Clinical and Experimental Pathology and Institut for Research on Cancer and Aging Nice (IRCAN) CNRS UMR /INSERM U Faculty of Medicine Nice University, Nice, France

  • CHU de Nice, Laboratory of Clinical and Experimental Pathology, Nice, France

  • CHU Nice, Hospital-Integrated Biobank BB- - , Nice, France

  • CHU de Nice, Thoracic Surgery Department, Nice, France

  • CHU Nice, Pneumology Department and Institut for Research on Cancer and Aging Nice (IRCAN) CNRS UMR /INSERM U Faculty of Medicine Nice University, Nice, France.

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Small cell lung cancer

Biomarkers

  • Circulating tumor cells

  • Programmed death-ligand 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved